Abstract
The 10th International Congress of Neuroimmunology, including the 10th European School of Neuroimmunology Course, was held by the International Society of Neuroimmunology in Sitges (Barcelona, Spain) on 26-30 October 2010. The conference covered a wide spectrum of issues and challenges in both basic science and clinical aspects of neuroimmunology. Data and ideas were shared through a variety of programs, including review talks and poster sessions. One of the topics of the congress was whether multiple sclerosis is a homogenous or heterogenous disease, clinically and pathologically, throughout its course.
MeSH terms
-
Animals
-
Antibodies, Monoclonal / pharmacology
-
Antibodies, Monoclonal / therapeutic use
-
B-Lymphocytes / drug effects*
-
B-Lymphocytes / immunology
-
Clinical Trials as Topic
-
Disease Progression
-
Humans
-
Immunotherapy*
-
Lymphocyte Depletion
-
Models, Animal
-
Multiple Sclerosis, Chronic Progressive / immunology*
-
Multiple Sclerosis, Chronic Progressive / physiopathology
-
Multiple Sclerosis, Chronic Progressive / therapy
-
Multiple Sclerosis, Relapsing-Remitting / immunology*
-
Multiple Sclerosis, Relapsing-Remitting / physiopathology
-
Multiple Sclerosis, Relapsing-Remitting / therapy
-
Neuritis
-
Neuroimmunomodulation
-
Spain
-
T-Lymphocyte Subsets / drug effects*
-
T-Lymphocyte Subsets / immunology